As TM4SF5 is known to bind and activate FAK 24 and c-Src family kinases (SFKs) 25, we confirmed the binding of endogenous FAK and c-Src to exogenous TM4SF5 in hepatic cancer cells (Figure 1B). The gene discussed is PTK2; the disease is liver cancer.